Yasho Industries LimitedQ1 FY27 Results & Financial Update

Industrial chemicals remain the primary growth segment, contributing nearly 89% of total revenue during Q1 FY27.

Exports remain a key pillar, contributing approximately 69% of total revenue during the quarter.

New brownfield and expansion capex projects are expected to generate an asset turnover ratio of approximately 2.5x.

Management views the electric vehicle transition as a 15-to-20-year horizon shift, posing no near-term terminal risk to lubricant additive demand over the next 10 years.

Over 50% of revenue is now secured through long-term quarterly, 6-monthly, or annual pricing contracts with formula-driven mechanisms rather than spot selling.

Approximately 60% to 65% of the capacity for the upcoming Rs. 250 crore capex expansion is already booked with identified customers and commitments.

The revised Rs. 250 crore capex for FY27 will primarily construct two new production buildings at the Pakhajan facility in two phases (Phase 1 of Rs. 100 crores and Phase 2 of Rs. 150 crores), with commercialization expected by FY28.

Company-wide capacity utilization improved to over 65% during Q1 FY27, supported by the successful ramp-up of capacities commissioned at the Pakhajan plant.

Management expressed confidence in sustaining current EBITDA margins of around 24% going forward due to optimized product mix and better facility utilization backed by customer commitments.

Selling prices are formula-driven based on raw material costs with marquee customers, allowing the company to maintain a constant EBITDA percentage regardless of absolute price fluctuations.

The working capital cycle improved significantly from 190 days to 143 days, aided by better inventory planning, receivables management, and cash deployment control.

Net debt to EBITDA improved to 1.86x as of June 30, 2026, compared to 3.75x at the end of Q4 FY26. The company expects to raise approximately Rs. 100 crores through borrowings in FY27 to fund its capex expansion.

Management revised its FY28 revenue target upwards to more than Rs. 1,600 crores.

The company targets 30% to 40% annual revenue growth over the next few years.

Management clarified that margin expansion was achieved through higher volumes, capacity utilization, and an improved product mix rather than older inventory realization, supporting future margin sustainability.

Management outlined that the Rs. 250 crore capex at Pakhajan will be split into Phase 1 (Rs. 100 crores operational by Q1 FY28) and Phase 2 (Rs. 150 crores operational by Q4 FY28), requiring a minimum of 15 months for erection and stabilization.

New capacity additions at Pakhajan will focus on industrial chemicals, incorporating both newly developed R&D molecules and scaling up existing products.

Products launched over the last 12 months carry 10% to 12% higher profit margins than older product lines.

Growth is primarily driven by US market recovery following tariff removals, along with new traction in Asia and Africa, despite ongoing container booking challenges and raw material supply tightness.